{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T22:19:25Z","timestamp":1774045165936,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.brachy.2025.12.005","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:52:44Z","timestamp":1769089964000},"page":"333-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improved outcomes in primary hepatocellular carcinoma adjacent to large vessels: A combined approach of MRI-guided radiofrequency ablation and 125I implantation"],"prefix":"10.1016","volume":"25","author":[{"given":"Xianhua","family":"Miao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2025.12.005_bib0001","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective","volume":"15","author":"Venook","year":"2010","journal-title":"Oncologist"},{"issue":"22","key":"10.1016\/j.brachy.2025.12.005_bib0002","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1002\/cncr.30237","article-title":"Comparison of hepatocellular carcinoma in Eastern versus Western populations","volume":"122","author":"Choo","year":"2016","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.brachy.2025.12.005_bib0003","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.brachy.2025.12.005_bib0004","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.ejrad.2011.03.043","article-title":"1.5T conventional MR-guided iodine-125 interstitial implants for hepatocellular carcinoma: feasibility and preliminary clinical experience","volume":"81","author":"Lin","year":"2012","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.brachy.2025.12.005_bib0005","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.crad.2013.11.013","article-title":"PET\/CT-guided percutaneous liver mass biopsies and ablations: targeting accuracy of a single 20 s breath-hold PET acquisition","volume":"69","author":"Shyn","year":"2014","journal-title":"Clin Radiol"},{"issue":"1","key":"10.1016\/j.brachy.2025.12.005_bib0006","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiology.217.1.r00se02119","article-title":"Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply","volume":"217","author":"Rossi","year":"2000","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.brachy.2025.12.005_bib0007","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1016\/j.ejrad.2012.05.007","article-title":"Treatment of hepatocellular carcinoma adjacent to large blood vessels using 1.5T MRI-guided percutaneous radiofrequency ablation combined with iodine-125 radioactive seed implantation","volume":"81","author":"Lin","year":"2012","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.brachy.2025.12.005_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.brachy.2025.12.005_bib0009","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s13104-015-1565-2","article-title":"Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinoma","volume":"8","author":"Takada","year":"2015","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.brachy.2025.12.005_bib0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1148\/radiol.14132958","article-title":"Image-guided tumor ablation: standardization of terminology and reporting criteria\u2013a 10-year update","volume":"273","author":"Ahmed","year":"2014","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.brachy.2025.12.005_bib0011","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/02656736.2018.1440017","article-title":"Hepatocellular carcinoma abutting large vessels: comparison of four percutaneous ablation systems","volume":"34","author":"Loriaud","year":"2018","journal-title":"Int J Hyperthermia"},{"issue":"12","key":"10.1016\/j.brachy.2025.12.005_bib0012","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00535-011-0452-4","article-title":"Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation","volume":"46","author":"Nishikawa","year":"2011","journal-title":"J Gastroenterol"},{"issue":"1","key":"10.1016\/j.brachy.2025.12.005_bib0013","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.suronc.2015.12.002","article-title":"Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma","volume":"25","author":"Hirokawa","year":"2016","journal-title":"Surg Oncol"},{"issue":"2","key":"10.1016\/j.brachy.2025.12.005_bib0014","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1148\/radiol.2017162756","article-title":"Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: systematic review of randomized controlled trials with meta-analysis and trial sequential analysis","volume":"287","author":"Xu","year":"2018","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.brachy.2025.12.005_bib0015","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00464-015-4295-6","article-title":"Minimally invasive surgery versus percutaneous radio frequency ablation for the treatment of single small (\u22643 cm) hepatocellular carcinoma: a case-control study","volume":"30","author":"Vitali","year":"2016","journal-title":"Surg Endosc"},{"issue":"4","key":"10.1016\/j.brachy.2025.12.005_bib0016","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2214\/AJR.10.4584","article-title":"Radiofrequency ablation for hepatocellular carcinoma abutting the diaphragm: comparison of effects of thermal protection and therapeutic efficacy","volume":"196","author":"Kang","year":"2011","journal-title":"Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.brachy.2025.12.005_bib0017","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1148\/radiol.13130387","article-title":"Comparison of combined transcatheter arterial chemoembolization and radiofrequency ablation with surgical resection by using propensity score matching in patients with hepatocellular carcinoma within Milan criteria","volume":"269","author":"Takuma","year":"2013","journal-title":"Radiology"},{"issue":"22","key":"10.1016\/j.brachy.2025.12.005_bib0018","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.4103\/0366-6999.218002","article-title":"Transcatheter arterial chemoembolization combined with simultaneous computed tomography-guided radiofrequency ablation for large hepatocellular carcinomas","volume":"130","author":"Zuo","year":"2017","journal-title":"Chin Med J"},{"issue":"6","key":"10.1016\/j.brachy.2025.12.005_bib0019","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jhep.2014.07.026","article-title":"Increased survival in hepatocellular carcinoma with iodine-125 implantation plus radiofrequency ablation: a prospective randomized controlled trial","volume":"61","author":"Chen","year":"2014","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.brachy.2025.12.005_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1148\/radiol.14140690","article-title":"Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis","volume":"275","author":"Lee","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.brachy.2025.12.005_bib0021","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejrad.2013.09.018","article-title":"Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance","volume":"83","author":"Clasen","year":"2014","journal-title":"Eur J Radiol"},{"issue":"11","key":"10.1016\/j.brachy.2025.12.005_bib0022","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1200\/JCO.2000.18.11.2210","article-title":"Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies","volume":"18","author":"Dawson","year":"2000","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2025.12.005_bib0023","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0360-3016(02)02864-X","article-title":"Dose-response relationship in local radiotherapy for hepatocellular carcinoma","volume":"54","author":"Park","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.brachy.2025.12.005_bib0024","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1089\/ars.2007.1628","article-title":"Detection and characterization of tumor hypoxia using pO2 histography","volume":"9","author":"Vaupel","year":"2007","journal-title":"Antioxid Redox Signal"},{"issue":"8","key":"10.1016\/j.brachy.2025.12.005_bib0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/02656730500271692","article-title":"Thermal ablation and high-temperature thermal therapy: overview of technology and clinical implementation","volume":"21","author":"Diederich","year":"2005","journal-title":"Int J Hyperthermia"},{"issue":"3","key":"10.1016\/j.brachy.2025.12.005_bib0026","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial","volume":"74","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.brachy.2025.12.005_bib0027","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1007\/s00330-006-0241-2","article-title":"CT-guided interstitial brachytherapy in the local treatment of extrahepatic, extrapulmonary secondary malignancies","volume":"16","author":"Wieners","year":"2006","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.brachy.2025.12.005_bib0028","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.26526","article-title":"Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma","volume":"58","author":"Yoshida","year":"2013","journal-title":"Hepatology"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T20:40:44Z","timestamp":1774039244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125003721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1538472125003721"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.12.005","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved outcomes in primary hepatocellular carcinoma adjacent to large vessels: A combined approach of MRI-guided radiofrequency ablation and 125I implantation","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}